|
gptkbp:instanceOf
|
gptkb:antibiotic
|
|
gptkbp:administeredBy
|
intramuscular injection
intravenous injection
|
|
gptkbp:ATCCode
|
gptkb:J01CF04
|
|
gptkbp:CASNumber
|
66-79-5
|
|
gptkbp:chemicalFormula
|
C19H19N3O5S
|
|
gptkbp:developedBy
|
gptkb:Beecham
|
|
gptkbp:discoveredIn
|
1960
|
|
gptkbp:eliminationHalfLife
|
0.5 to 1 hour
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
oxacillin
|
|
gptkbp:isomerOf
|
gptkb:cloxacillin
gptkb:dicloxacillin
gptkb:flucloxacillin
|
|
gptkbp:KEGGID
|
gptkb:D08304
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits bacterial cell wall synthesis
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
401.44 g/mol
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:PubChem_CID
|
gptkb:DB00713
CHEMBL1377
6196
|
|
gptkbp:resistantTo
|
gptkb:penicillinase
|
|
gptkbp:sideEffect
|
diarrhea
allergic reaction
rash
liver dysfunction
|
|
gptkbp:UNII
|
4OR63N9945
|
|
gptkbp:usedFor
|
treatment of staphylococcal infections
|
|
gptkbp:bfsParent
|
gptkb:MSSA
gptkb:methicillin-resistant_Staphylococcus_aureus_(MRSA)
|
|
gptkbp:bfsLayer
|
6
|